Free Trial

Cigna Group $CI Shares Purchased by Mather Group LLC.

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Mather Group LLC increased its Cigna position by 57.9% in the third quarter, purchasing 3,399 additional shares and bringing its holdings to 9,269 shares worth approximately $2.52 million. Institutional investors collectively own 86.99% of Cigna stock.
  • Wall Street maintains a positive outlook, with 15 analysts rating Cigna a Buy and eight a Hold. The stock has an average “Moderate Buy” rating and an average price target of $338.24, above its cited trading price of $302.48.
  • Cigna reported quarterly earnings of $7.78 per share, beating estimates, while revenue rose 6.7% year over year to $71.56 billion. The company also paid a quarterly dividend of $1.56, equivalent to a 2.1% annualized yield.
  • Five stocks to consider instead of Cigna Group.

Mather Group LLC. raised its position in Cigna Group (NYSE:CI - Free Report) by 57.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,269 shares of the health services provider's stock after buying an additional 3,399 shares during the period. Mather Group LLC.'s holdings in Cigna Group were worth $2,520,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Osbon Capital Management LLC acquired a new position in shares of Cigna Group during the second quarter valued at approximately $26,000. Cedar Mountain Advisors LLC lifted its position in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after acquiring an additional 68 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Cigna Group in the second quarter valued at approximately $29,000. Fiduciary Financial Advisors acquired a new stake in shares of Cigna Group in the second quarter worth approximately $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Cigna Group in the second quarter worth approximately $34,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Royal Bank Of Canada reiterated an "outperform" rating and set a $337.00 price target on shares of Cigna Group in a research report on Thursday, October 1st. Piper Sandler set a $370.00 price objective on Cigna Group and gave the company an "overweight" rating in a report on Friday, October 2nd. Wells Fargo & Company raised their price objective on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. UBS Group reaffirmed a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Finally, Guggenheim lifted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of "Moderate Buy" and an average price target of $338.24.

Read Our Latest Stock Analysis on Cigna Group

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 617 shares of the company's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 22,730 shares of company stock worth $6,293,359. Insiders own 0.60% of the company's stock.

Cigna Group Price Performance

CI stock traded up $3.67 during mid-day trading on Friday, reaching $302.48. The company's stock had a trading volume of 1,545,464 shares, compared to its average volume of 1,692,376. The stock has a market cap of $79.93 billion, a PE ratio of 12.51, a P/E/G ratio of 1.01 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $311.34. The company's 50 day moving average is $278.87 and its two-hundred day moving average is $281.82.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. The business had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business's revenue was up 6.7% on a year-over-year basis. During the same period last year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts expect that Cigna Group will post 30.50 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a $1.56 dividend. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group's dividend payout ratio (DPR) is 25.82%.

Cigna Group Company Profile

(Free Report)

The Cigna Group NYSE: CI is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.

Read More

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines